Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    supriya kashyap kashyap
    supriya kashyap kashyap
      • Home
      • supriya kashyap...

      Articles By : supriya kashyap kashyap

      Roches Alecensa notches trial win against Pfizers Xalkori

      Roche's Alecensa notches trial win against Pfizer's Xalkori

      supriya kashyap kashyap16 April 2017 10:23 AM IST
      Zurich : Roche's Alecensa kept people with a specific lung cancer alive longer without their disease progressing than Pfizer's Xalkori, the Swiss...
      Hologic faces US patent lawsuit over menstrual bleeding device

      Hologic faces US patent lawsuit over menstrual bleeding device

      supriya kashyap kashyap16 April 2017 10:23 AM IST
      Medical device maker Hologic Inc has been hit with a lawsuit alleging its product for treating heavy menstrual bleeding infringes patented technology...
      APAC Biotech gets Indian FDA Approval for Autologous Dendritic Cell-based Immuno-oncology Product, APCEDEN®

      APAC Biotech gets Indian FDA Approval for Autologous Dendritic Cell-based Immuno-oncology Product, APCEDEN®

      supriya kashyap kashyap16 April 2017 10:20 AM IST
      A first-of-its-kind Indian biotechnology company, APAC Biotech, was granted with a commercial license by Indian FDA (CDSCO - Central Drugs Standard...
      Eli Lilly defeats Teva appeal over Alimta cancer drug

      Eli Lilly defeats Teva appeal over Alimta cancer drug

      supriya kashyap kashyap16 April 2017 10:14 AM IST
      A U.S. appeals court said Eli Lilly and Co may block Teva Pharmaceutical Industries Ltd from selling a generic equivalent of its top-selling lung...
      Abbott Lab to buy Alere for Whooping 4.48 billion dollars

      Abbott Lab to buy Alere for Whooping 4.48 billion dollars

      supriya kashyap kashyap16 April 2017 10:02 AM IST
      Diversified healthcare company Abbott Laboratories has agreed to buy Alere Inc for about $4.48 billion, ending a prolonged legal battle over its plan...
      USFDA declines to approve Eli Lilly and Incyte arthritis drug Olumiant

      USFDA declines to approve Eli Lilly and Incyte arthritis drug Olumiant

      supriya kashyap kashyap15 April 2017 11:13 AM IST
      The U.S. Food and Drug Administration declined to approve a new drug for rheumatoid arthritis made by Eli Lilly and Co and partner Incyte Corp, the...
      Philips receives FDA clearance to market Philips IntelliSite Pathology Solution for primary diagnostic use in the US

      Philips receives FDA clearance to market Philips IntelliSite Pathology Solution for primary diagnostic use in the US

      supriya kashyap kashyap15 April 2017 9:40 AM IST
      Royal Philips, a global leader in health technology, announced it has received regulatory clearance (via De Novo classification) from the U.S. Food...
      Dr Reddys recalls 1,728 bottles of dementia drug from US

      Dr Reddy's recalls 1,728 bottles of dementia drug from US

      supriya kashyap kashyap15 April 2017 9:34 AM IST
      New Delhi : Drug firm Dr Reddy's Laboratories is recalling 1,728 bottles of Rivastigmine Tartrate capsules, used for treatment of dementia, due to...
      US FDA warns Abbott Labs over heart device problems

      US FDA warns Abbott Labs over heart device problems

      supriya kashyap kashyap14 April 2017 1:08 PM IST
      The U.S. Food and Drug Administration issued a warning letter to Abbott Laboratories, citing manufacturing flaws with a range of cardiovascular...
      ASPA lobbies for mandatory authentication for medicines

      ASPA lobbies for mandatory authentication for medicines

      supriya kashyap kashyap14 April 2017 11:23 AM IST
      Kolkata : The Authentication Solution Providers Association (ASPA) emphasised the need for specific anti-counterfeit laws in the country to stem the...
      USFDA issues warning letter to Mylan for Nashik facility

      USFDA issues warning letter to Mylan for Nashik facility

      supriya kashyap kashyap14 April 2017 11:20 AM IST
      New Delhi : The US health regulator has issued a warning letter to drug firm Mylan for violations of good manufacturing norms, including data...
      Cipla arm completes acquisition of South Africa-based firm

      Cipla arm completes acquisition of South Africa-based firm

      supriya kashyap kashyap14 April 2017 11:19 AM IST
      New Delhi : Drug firm Cipla said it's subsidiary in South Africa has completed the acquisition of Anmarate (Pty) Ltd, South Africa, a deal estimated...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok